Pharmacyclics LLC, An AbbVie Company
Pharmacyclics is focused on developing and commercializing small-molecule drugs for the treatment of cancer and immune-mediated diseases. The company’s mission is to improve the quality of life, increase duration of life and resolve serious unmet medical needs. Pharmacyclics markets IMBRUVICA and has two product candidates in clinical development. To learn more, visit Pharmacyclics.com.